The DOI matches its Crossref record; 337 of the 337 references it cites were found in a registry or an index.
Taxanes, microtubules and chemoresistant breast cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–337 of 337
The role of β-tubulin isotypes in resistance to antimitotic drugs
Burkhart, C. A., Kavallaris, M., & Horwitz, S. B. (2001) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(00)00022-6 · Cited by 198
Lee, L.-F., Li, G., Templeton, D. J., & Ting, J. P.-Y. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.43.28253 · Cited by 197
The development and clinical use of trastuzumab (Herceptin).
Harries, M., & Smith, I. (2002) · Endocrine-related cancer · doi:10.1677/erc.0.0090075 · Cited by 196
(2001) · PubMed · Cited by 193
Regulating the onset of mitosis
Ohi, R., & Gould, K. L. (1999) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(99)80036-2 · Cited by 192
Altmann, K.-H., Wartmann, M., & O’Reilly, T. (2000) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(00)00009-3 · Cited by 191
Short interfering RNAs as a tool for cancer gene therapy
Izquierdo, M. (2005) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700791 · Cited by 190
A. Curmi, P., Gavet, O., Charbaut, E., Ozon, S., Lachkar-Colmerauer, S., Manceau, V., Siavoshian, S., Maucuer, A., & Sobel, A. (1999) · Cell Structure and Function · doi:10.1247/csf.24.345 · Cited by 189
Rosell, R., Scagliotti, G., Danenberg, K. D., Lord, R. V., Bepler, G., Novello, S., Cooc, J., Crinò, L., Sánchez, J. J., Taron, M., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206419 · Cited by 188
Lafarge, S., Sylvain, V., Ferrara, M., & Bignon, Y.-J. (2001) · Oncogene · doi:10.1038/sj.onc.1204812 · Cited by 187
Effect of stathmin on the sensitivity to antimicrotubule drugs in human breast cancer.
Alli, E., Bash-Babula, J., Yang, J., & Hait, W. N. (2002) · PubMed · Cited by 187
Phosphorylation of microtubule‐associated protein tau by isoforms of c‐Jun N‐terminal kinase (JNK)
Yoshida, H., Hastie, C. J., McLauchlan, H., Cohen, P., & Goedert, M. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02479.x · Cited by 183
Kitazaki, T., Oka, M., Nakamura, Y., Tsurutani, J., Doi, S., Yasunaga, M., Takemura, M., Yabuuchi, H., Soda, H., & Kohno, S. (2005) · Lung Cancer · doi:10.1016/j.lungcan.2005.03.035 · Cited by 182
Antisense oligonucleotides to class III β-tubulin sensitize drug-resistant cells to Taxol
Kavallaris, M., Burkhart, C. A., & Horwitz, S. B. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690507 · Cited by 179
Identification, localization and characterization of the human γ-synuclein gene
Lavedan, C., Leroy, E., Dehejia, A., Buchholtz, S., Dutra, A., Nussbaum, R. L., & Polymeropoulos, M. H. (1998) · Human Genetics · doi:10.1007/s004390050792 · Cited by 179
Liu, H., Liu, W., Wu, Y., Zhou, Y., Xue, R., Luo, C., Wang, L., Zhao, W., Jiang, J., & Liu, J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1089 · Cited by 179
Shichiri, M., Yoshinaga, K., Hisatomi, H., Sugihara, K., & Hirata, Y. (2002) · PubMed · Cited by 177
Survivin: A Protein with Dual Roles in Mitosis and Apoptosis
WHEATLEY, S., & MCNEISH, I. (2005) · International Review of Cytology · doi:10.1016/s0074-7696(05)47002-3 · Cited by 168
Serine-70 is one of the critical sites for drug-induced Bcl2 phosphorylation in cancer cells.
Haldar, S. M., Basu, A., & Croce, C. M. (1998) · PubMed · Cited by 166
Novel Aspects of Natural and Modified Vinca Alkaloids
Duflos, A., Kruczynski, A., & Barret, J.-M. (2012) · Current Medicinal Chemistry-Anti-Cancer Agents · doi:10.2174/1568011023354452 · Cited by 166
Dong, Q. G., Sclabas, G. M., Fujioka, S., Schmidt, C., Peng, B., Wu, T., Tsao, M.-S., Evans, D. B., Abbruzzese, J. L., McDonnell, T. J., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205848 · Cited by 166
Monastrol Inhibition of the Mitotic Kinesin Eg5
Cochran, J. C., Gatial, J. E., Kapoor, T. M., & Gilbert, S. P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413140200 · Cited by 164
Paclitaxel And Docetaxel Resistance: Molecular Mechanisms and Development of New Generation Taxanes
Galletti, E., Magnani, M., Renzulli, M. L., & Botta, M. (2007) · ChemMedChem · doi:10.1002/cmdc.200600308 · Cited by 164
Bunker, J. M., Wilson, L., Jordan, M. A., & Feinstein, S. C. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-01-0062 · Cited by 164
A requirement for breast-cancer-associated gene 1 (BRCA1) in the spindle checkpoint
Wang, R.-H., Yu, H., & Deng, C.-X. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407585101 · Cited by 163
Attachment and tension in the spindle assembly checkpoint
Zhou, J., Yao, J., & Joshi, H. C. (2002) · Journal of Cell Science · doi:10.1242/jcs.00029 · Cited by 162
Fujita, T., Doihara, H., Kawasaki, K., Takabatake, D., Takahashi, H., Washio, K., Tsukuda, K., Ogasawara, Y., & Shimizu, N. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6602926 · Cited by 161
Penson, R. T., Oliva, E., Skates, S. J., Glyptis, T., Fuller, A. F., Goodman, A., & Seiden, M. V. (2004) · Gynecologic Oncology · doi:10.1016/j.ygyno.2003.11.053 · Cited by 161
Chabalier, C., Lamare, C., Racca, C., Privat, M., Valette, A., & Larminat, F. (2006) · Cell Cycle · doi:10.4161/cc.5.9.2726 · Cited by 159
Chuang, S.-E., Yeh, P.-Y., Lu, Y.-S., Lai, G.-M., Liao, C.-M., Gao, M., & Cheng, A.-L. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)00931-0 · Cited by 159
Zhang, C. C., Yang, J.-M., White, E., Murphy, M., Levine, A., & Hait, W. N. (1998) · Oncogene · doi:10.1038/sj.onc.1201658 · Cited by 159
Martello, L. A., Verdier‐Pinard, P., Shen, H. J., He, L., Torres, K. E., Orr, G. A., & Horwitz, S. B. (2003) · PubMed · Cited by 158
How Do so Few Control so Many?
Nasmyth, K. (2005) · Cell · doi:10.1016/j.cell.2005.03.006 · Cited by 158
Identification of a MAD2‐binding protein, CMT2, and its role in mitosis
Habu, T., Kim, S. H., Weinstein, J., & Matsumoto, T. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf659 · Cited by 157
Hari, M., Loganzo, F., Annable, T., Tan, X., Musto, S., Morilla, D. B., Nettles, J. H., Snyder, J. P., & Greenberger, L. M. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0190 · Cited by 156
BRCA1 and GADD45 mediated G2/M cell cycle arrest in response to antimicrotubule agents
Mullan, P. B., Quinn, J. E., Gilmore, P. M., McWilliams, S., Andrews, H. N., Gervin, C., McCabe, N., McKenna, S., White, P., Song, Y., et al. (2001) · Oncogene · doi:10.1038/sj.onc.1204712 · Cited by 154
Mad2 binding to Mad1 and Cdc20, rather than oligomerization, is required for the spindle checkpoint
Sironi, L., Melixetian, M. B., Faretta, M., Prosperini, E., Helin, K., & Musacchio, A. (2001) · The EMBO Journal · doi:10.1093/emboj/20.22.6371 · Cited by 154
BRCA1 Facilitates Stress-induced Apoptosis in Breast and Ovarian Cancer Cell Lines
Thangaraju, M., Kaufmann, S. H., & Couch, F. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005824200 · Cited by 153
Do β-tubulin mutations have a role in resistance to chemotherapy?
Berrieman, H. K., Lind, M., & Cawkwell, L. (2004) · The Lancet Oncology · doi:10.1016/s1470-2045(04)01411-1 · Cited by 153
Fisher, B., Redmond, C. K., Wickerham, D. L., Bowman, D., Schipper, H., Wolmark, N., Sass, R., Fisher, E. R., Jochimsen, P. R., & Legault-Poisson, S. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.5.572 · Cited by 151
A β-Tubulin Leucine Cluster Involved in Microtubule Assembly and Paclitaxel Resistance
Gonzalez‐Garay, M. L., Chang, L., Cabral, F., Blade, K. L., & Menick, D. R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.34.23875 · Cited by 150
Changes in Microtubule Protofilament Number Induced by Taxol Binding to an Easily Accessible Site
Díaz, J. F., Valpuesta, J., Chacón, P., Diakun, G. P., & Andreu, J. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.50.33803 · Cited by 149
Paradiso, A., Simone, G., Petroni, S., Leone, B. A., Vallejo, C. T., Lacava, J. A., Romero, A., Machiavelli, M. R., Lena, M. D., Allegra, C. J., et al. (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.0964 · Cited by 148
p53 Gene Status and Response to Platinum/Paclitaxel-Based Chemotherapy in Advanced Ovarian Carcinoma
Lavarino, C. E., Pilotti, S., Oggionni, M., Gatti, L., Perego, P., Bresciani, G., Pierotti, M. A., Scambia, G., Ferrandina, G., Fagotti, A., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.23.3936 · Cited by 147
p53 status does not affect sensitivity of human ovarian cancer cell lines to paclitaxel.
Debernardis, D., Siré, E. G., de Feudis, P., Vikhanskaya, F., Valenti, M., Russo, P., Parodi, S., D’Incalci, M., & Broggini, M. (1997) · PubMed · Cited by 146
Masuda, A., & Takahashi, T. (2002) · Oncogene · doi:10.1038/sj.onc.1205566 · Cited by 145
Wheatley, S. P., Henzing, A. J., Dodson, H., Khaled, W. T., & Earnshaw, W. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311299200 · Cited by 139
Asnaghi, L., Calastretti, A., Bevilacqua, A., D’Agnano, I., Gatti, G., Canti, G. L., Delia, D., Capaccioli, S., & Nicolin, A. (2004) · Oncogene · doi:10.1038/sj.onc.1207698 · Cited by 133
Gene expression and mitotic exit induced by microtubule-stabilizing drugs.
Chen, J.-G., Yang, C.-P. H., Cammer, M., & Horwitz, S. B. (2003) · PubMed · Cited by 132
Spindle Checkpoint Requires Mad1-bound and Mad1-free Mad2
Chung, E., & Chen, R. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.02-01-0003 · Cited by 130
Biomarkers and Multiple Drug Resistance in Breast Cancer
O’Driscoll, L., & CLYNES, M. M. (2006) · Current Cancer Drug Targets · doi:10.2174/156800906777723958 · Cited by 128
Tan, M., Jing, T., Lan, K., Neal, C. L., Li, P., Lee, S., Fang, D., Nagata, Y., Liu, J., Arlinghaus, R. B., et al. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00510-5 · Cited by 128
André, F., Hatzis, C., Anderson, K., Sotiriou, C. P., Mazouni, C., Mejia, J. A., Wang, B., Hortobágyi, G. N., Symmans, W. F., & Pusztai, L. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2078 · Cited by 128
Predictive factors for response to docetaxel in human breast cancers
Noguchi, S. (2006) · Cancer Science · doi:10.1111/j.1349-7006.2006.00265.x · Cited by 127
Plosker, G. L., & Keam, S. J. (2006) · Drugs · doi:10.2165/00003495-200666040-00005 · Cited by 127
Pan, Z., Bruening, W., Giasson, B. I., Lee, V. M. ‐., & Godwin, A. K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201650200 · Cited by 125
Evidence for two distinct binding sites for tau on microtubules
Makrides, V., Massie, M. R., Feinstein, S. C., & Lew, J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400992101 · Cited by 123
Mabuchi, S., Ohmichi, M., Nishio, Y., Hayasaka, T., Kimura, A., Ohta, T., Kawagoe, J., Takahashi, K., Yada-Hashimoto, N., Seino-Noda, H., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0958 · Cited by 120
Roles of BRCA1 in centrosome duplication
Deng, C. (2002) · Oncogene · doi:10.1038/sj.onc.1205713 · Cited by 120
Pharmacologic approaches to reversing multidrug resistance.
Sikic, B. I. (1997) · PubMed · Cited by 117
Loss of p21Waf1/Cip1 sensitizes tumors to radiation by an apoptosis-independent mechanism.
Wouters, B. G., Giaccia, A. J., Denko, N. C., et al. (1997) · PubMed · Cited by 116
The immunopharmacology of paclitaxel (Taxol®), docetaxel (Taxotere®), and related agents
Fitzpatrick, F. A., & Wheeler, R. H. (2003) · International Immunopharmacology · doi:10.1016/j.intimp.2003.08.007 · Cited by 115
Mechanisms of Mitotic Cell Death Induced by Chemotherapy-Mediated G2 Checkpoint Abrogation
Vogel, C., Hager, C., & Bastians, H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2548 · Cited by 115
Kasai, T., Iwanaga, Y., Iha, H., & Jeang, K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110295200 · Cited by 113
Identification of a gamma-tubulin-binding domain in BRCA1.
Hsu, L., Doan, T. P. T., & White, R. L. (2001) · PubMed · Cited by 111
McDaid, H. M., & Horwitz, S. B. (2001) · Molecular Pharmacology · doi:10.1124/mol.60.2.290 · Cited by 111
Yu, H. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200601172 · Cited by 110
Luo, X. N., Mookerjee, B., Ferrari, A. C., Mistry, S. J., & Atweh, G. F. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34062-0 · Cited by 108
The Seco-Taxane IDN5390 Is Able to Target Class III β-Tubulin and to Overcome Paclitaxel Resistance
Ferlini, C., Raspaglio, G., Mozzetti, S., Cicchillitti, L., Filippetti, F., Gallo, D., Fattorusso, C., Campiani, G., & Scambia, G. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3065 · Cited by 107
Oakley, B. R. (2000) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)01857-2 · Cited by 107
Mad2 and BubR1 Function in a Single Checkpoint Pathway that Responds to a Loss of Tension
Shannon, K. B., Canman, J. C., & Salmon, E. D. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-03-0137 · Cited by 104
Dumontet, C., Isaac, S., Souquet, P.-J., Bejui-Thivolet, F., Pachéco, Y., Peloux, N., Frankfurter, A. J., Ludueña, R. F., & Pérol, M. (2005) · PubMed · Cited by 101
Mig-6, Signal Transduction, Stress Response and Cancer
Zhang, Y.-W., & Woude, G. F. V. (2007) · Cell Cycle · doi:10.4161/cc.6.5.3928 · Cited by 100
Overexpression of the stathmin gene in a subset of human breast cancer
Bièche, I., Lachkar, S., Becette, V., Cifuentes-Díaz, C., Sobel, A., Lidereau, R., & Curmi, P. A. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.565 · Cited by 100
Microtubule-Targeting Drugs Induce Bcl-2 Phosphorylation and Association with Pin1
Pathan, N., Aimé, C., Kitada, S., Haldar, S., & Reed, J. C. (2001) · Neoplasia · doi:10.1038/sj.neo.7900131 · Cited by 97
Vikhanskaya, F., Vignati, S., Beccaglia, P., Ottoboni, C., Russo, P., D’Incalci, M., & Broggini, M. (1998) · Experimental Cell Research · doi:10.1006/excr.1998.4018 · Cited by 96
Yang, C.-H., Huang, C.-J., Yang, C.-S., Chu, Y.-C., Cheng, A., Whang‐Peng, J., & Yang, P. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0641 · Cited by 95
Yagüe, E., Higgins, C. F., & Raguz, S. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302269 · Cited by 94
Banerjee, A. K. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00269-3 · Cited by 94
Bergstralh, D. T., & Ting, J. P. ‐. (2006) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2006.01.004 · Cited by 94
Kienitz, A., Vogel, C., Morales, I., Müller, R., & Bastians, H. (2005) · Oncogene · doi:10.1038/sj.onc.1208589 · Cited by 92
Lack of correlation between mitotic arrest or apoptosis and antitumor effect of docetaxel
Schimming, R., Mason, K. A., Hunter, N., Weil, M. M., Kishi, K., & Milas, L. (1999) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050879 · Cited by 89
The Survivin/Aurora B Complex: Its Role in Coordinating Tension and Attachment
Lens, S. M. A., & Medema, R. H. (2003) · Cell Cycle · doi:10.4161/cc.2.6.559 · Cited by 87
Chromosomal Instability, Colorectal Cancer and Taxane Resistance
Swanton, C., Tomlinson, I. P. M., & Downward, J. (2006) · Cell Cycle · doi:10.4161/cc.5.8.2682 · Cited by 87
Shen, S., Huang, T., Jee, S., & Kuo, M. L. (1998) · PubMed · Cited by 87
Nicoletti, M. I., Valoti, G., Giannakakou, P., Zhan, Z., Kim, J. H., Lucchini, V., Landoni, F., Mayo, J. G., Giavazzi, R., & Fojo, T. (2001) · PubMed · Cited by 85
Inaba, S., Li, C., Shi, Y. E., et al. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-005-6938-0 · Cited by 84
Mechanisms of cancer: multidrug resistance
Filipits, M. (2004) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2004.10.001 · Cited by 84
Suppression of centromere dynamics by Taxol in living osteosarcoma cells.
Kelling, J., Sullivan, K. F., Wilson, L., & Jordan, M. A. (2003) · PubMed · Cited by 83
Effects of stathmin inhibition on the mitotic spindle
Iancu‐Rubin, C., Mistry, S. J., Arkin, S., Wallenstein, S. R., & Atweh, G. F. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.5.909 · Cited by 83
Toppmeyer, D., Seidman, A. D., Pollak, M., Russell, C. A., Tkaczuk, K., Verma, S., Overmoyer, B. A., Garg, V., Ette, E., Harding, M. W., et al. (2002) · PubMed · Cited by 82
Merrick, S. E., Demoise, D. C., & Lee, V. M. ‐. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.10.5589 · Cited by 81
Wagner, P., Wang, B., Clark, E. A., Lee, H., Rouzier, R., & Pusztai, L. (2005) · Cell Cycle · doi:10.4161/cc.4.9.2038 · Cited by 80
Šale, S., Sung, R. K., Shen, P., Yu, K. M., Wang, Y. C., Durán, G. E., Kim, J.-H., Fojo, T., Oefner, P. J., & Sikic, B. I. (2002) · PubMed · Cited by 79
Fujie, Y., Yamamoto, H., Ngan, C. Y., Takagi, A., Hayashi, T., Suzuki, R., Ezumi, K., Takemasa, I., Ikeda, M., Sekimoto, M., et al. (2005) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyi130 · Cited by 75
Dissociation of Bax from a Bcl-2/Bax Heterodimer Triggered by Phosphorylation of Serine 70 of Bcl-2
Shitashige, M., Toi, M., Yano, T., Shibata, M. S., Matsuo, Y., & Shibasaki, F. (2001) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a003044 · Cited by 74
Shingu, T., Yamada, K., Hara, N., Moritake, K., Osago, H., Terashima, M., Uemura, T., Yamasaki, T., & Tsuchiya, M. (2003) · PubMed · Cited by 74
Telling Cells How to Die: Docetaxel Therapy in Cancer Cell Lines
Hernández‐Vargas, H., Palacios, J., & Moreno‐Bueno, G. (2007) · Cell Cycle · doi:10.4161/cc.6.7.4050 · Cited by 69
Wang, S., Wang, Z., Boise, L., Dent, P., & Grant, S. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0669 · Cited by 66
Current options in treatment of anthracycline-resistant breast cancer
Kröger, N. M., Achterrath, W., Hegewisch-Becker, S., Mross, K. B., & Zander, A. R. (1999) · Cancer Treatment Reviews · doi:10.1053/ctrv.1999.0137 · Cited by 66
Crystallographic Structure of Tubulin. Implications for Dynamics and Drug Binding.
Downing, K. H., & Nogales, E. (1999) · Cell Structure and Function · doi:10.1247/csf.24.269 · Cited by 66
Villeneuve, D. J., Hembruff, S. L., Veitch, Z. W. N., Cecchetto, M., Dew, W. A., & Parissenti, A. M. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-005-9026-6 · Cited by 64
Development of Novel Chemotherapeutic Agents to Evade the Mechanisms of Multidrug Resistance (MDR)
Lee, J. J., & Swain, S. M. (2005) · Seminars in Oncology · doi:10.1053/j.seminoncol.2005.09.013 · Cited by 64
Microtubule-Targeting Drugs Induce Bcl-2 Phosphorylation and Association with Pin1
Pathan, N., Aimé, C., Kitada, S., et al. (2001) · Neoplasia · doi:10.1038/sj.neo.7900213 · Cited by 64
Huang, Y., & Fan, W. (2002) · Molecular Pharmacology · doi:10.1124/mol.61.1.105 · Cited by 63
Singh, V. K., Zhou, Y., Marsh, J. A., Uversky, V. N., Forman-Kay, J. D., Liu, J., & Jia, Z. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1820 · Cited by 62
Warnick, C. T., Dabbas, B., Ford, C. D., & Strait, K. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103088200 · Cited by 61
Tóthová, E., Fričová, M., Stecova, N., Kafková, A., & Elbertová, A. (2002) · PubMed · Cited by 61
Manna, T. K., Thrower, D., Miller, H. P., Curmi, P. A., & Wilson, L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m510661200 · Cited by 60
Kolfschoten, G. M., Hulscher, T. M., Duyndam, M. C. A., Pinedo, H. M., & Boven, E. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00895-4 · Cited by 59
Poruchynsky, M. S., Giannakakou, P., Ward, Y., Bulinski, J. C., Telford, W. G., Robey, R. W., & Fojo, T. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00804-8 · Cited by 59
Centrosomes and checkpoints: the MPS1 family of kinases
Winey, M., & Huneycutt, B. J. (2002) · Oncogene · doi:10.1038/sj.onc.1205712 · Cited by 58
Yang, Z., Guo, J., Li, N., Qian, M., Sheng Nian, W. A. N. G., & Zhu, X. L. (2003) · Cell Research · doi:10.1038/sj.cr.7290172 · Cited by 57
Mutational analysis of the class I β‐tubulin gene in human breast cancer
Hasegawa, S., Miyoshi, Y., Egawa, C., Ishitobi, M., Tamaki, Y., Monden, M., & Noguchi, S. (2002) · International Journal of Cancer · doi:10.1002/ijc.10575 · Cited by 56
Ueno, H., Kondo, E., Yamamoto‐Honda, R., Tobe, K., Nakamoto, T., Sasaki, K., Mitani, K., Furusaka, A., Tanaka, T., Tsujimoto, Y., et al. (2000) · Molecular Biology of the Cell · doi:10.1091/mbc.11.2.735 · Cited by 54
Basu, A., DuBois, G., & Haldar, S. (2006) · Frontiers in bioscience · doi:10.2741/1900 · Cited by 52
Poddar, A., Stukenberg, P. T., & Burke, D. J. (2005) · Eukaryotic Cell · doi:10.1128/ec.4.5.867-878.2005 · Cited by 52
Emerging role of taxanes in adjuvant and neoadjuvant therapy for breast cancer
Goble, S. A., & Bear, H. D. (2003) · Surgical Clinics of North America · doi:10.1016/s0039-6109(03)00071-9 · Cited by 50
Panda, D., Miller, H. P., & Wilson, L. (2002) · Biochemistry · doi:10.1021/bi011767m · Cited by 49
Schneider, J., Lucas, R., Sánchez, J., Ruibal, Á., Tejerina, A., & Martín, M. (2000) · PubMed · Cited by 47
Tubulin-Associated Drug Targets: Aurora Kinases, Polo-like Kinases, and Others
WARNER, S., GRAY, P., & VonHoff, D. D. (2006) · Seminars in Oncology · doi:10.1053/j.seminoncol.2006.04.007 · Cited by 46
p53 expression and resistance against paclitaxel in patients with metastatic breast cancer
Schmidt, M., Bachhuber, A., Victor, A., Steiner, E., Mahlke, M., Lehr, H., Pilch, H., Weikel, W., & Knapstein, P. G. (2003) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-003-0430-1 · Cited by 46
Gilmore, P. M., McCabe, N., Quinn, J. E., Kennedy, R. D., Gorski, J. J., Andrews, H. N., McWilliams, S., Carty, M., Mullan, P. B., Duprex, W. P., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-4080 · Cited by 45
Characterization of Regions in hsMAD1 Needed for Binding hsMAD2
Iwanaga, Y., Kasai, T., Kibler, K. V., & Jeang, K.-T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110666200 · Cited by 43
Biochemical genetic analysis of indanocine resistance in human leukemia.
Hua, X. H., Genini, D., Gussio, R., Tawatao, R. I., Shih, H. A., Kipps, T. J., Carson, D. A., & Leoni, L. M. (2001) · PubMed · Cited by 43
Recent Progress in Discovery and Development of Antimitotic Agents
Kiselyov, A. S., Balakin, K. V., Tkachenko, S. E., Savchuk, N., & Ivachtchenko, A. V. (2007) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152007780058650 · Cited by 43
Mutation of the class I β-tubulin gene does not predict response to paclitaxel for breast cancer
Maeno, K., Ito, K., Hama, Y., Shingū, K., Kimura, M., Sano, M., Nakagomi, H., Tsuchiya, S., & Fujimori, M. (2003) · Cancer Letters · doi:10.1016/s0304-3835(03)00279-9 · Cited by 40
Ham, Y., Choi, J., Chun, K., Joo, S.-H., & Lee, S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302997200 · Cited by 38
Modi, S., DiGiovanna, M. P., Zhao, L., Moskowitz, C. S., Panageas, K. S., Poznak, C. H. V., Hudis, C. A., Norton, L., Tan, L. K., Stern, D. F., et al. (2005) · Cancer Investigation · doi:10.1080/07357900500201301 · Cited by 37
Explaining the oligomerization properties of the spindle assembly checkpoint protein Mad2
Antoni, A. D., Sala, V., & Musacchio, A. (2005) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2004.1618 · Cited by 37
BRCA1—A good predictive marker of drug sensitivity in breast cancer treatment?
Mullan, P. B., Gorski, J. J., & Harkin, D. P. (2006) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.07.001 · Cited by 34
Dissecting Cancer Pathways and Vulnerabilities with RNAiPreprint
Westbrook, T. F., Stegmeier, F. P., & Elledge, S. J. (2005) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2005.70.031 · Cited by 34
Dynamics of the mitotic spindle--potential therapeutic targets.
Miyamoto, D. T., Perlman, Z. E., Mitchison, T. J., et al. (2003) · PubMed · Cited by 32
Brady, H. J. M., & Gil‐Gómez, G. (1999) · Results and problems in cell differentiation · doi:10.1007/978-3-540-69184-6_7 · Cited by 16
Dart, D. A., Picksley, S. M., Cooper, P. A., Double, J. A., & Bibby, M. C. (2004) · International Journal of Oncology · doi:10.3892/ijo.24.1.115 · Cited by 16
Rantanen, V. T., Engblom, P., Raitanen, M., Hietanen, S., Haarala, M., Grénman, S., & Syrjänen, S. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00119-3 · Cited by 13
Long term survivors of childhood brain cancer have an increased risk for cardiovascular disease
(2000) · Pure Amsterdam UMC · doi:10.1002/(sici)1097-0142(20000501)88:9
Cited by
Microtubules and resistance to tubulin-binding agents
Kavallaris, M. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2803 · Cited by 1,120
Natural compounds for cancer treatment and prevention
Nobili, S., Lippi, D., Witort, E., Donnini, M., Bausi, L., Mini, E., & Capaccioli, S. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.01.017 · Cited by 780
Paclitaxel’s Mechanistic and Clinical Effects on Breast Cancer
Abu Samaan, T. M., Samec, M., Liskova, A., Kubatka, P., & Büsselberg, D. (2019) · Biomolecules · doi:10.3390/biom9120789 · Cited by 569
Mechanisms of resistance in castration-resistant prostate cancer (CRPC).
Chandrasekar, T., Yang, J. C., Gao, A. C., & Evans, C. P. (2015) · PubMed · doi:10.3978/j.issn.2223-4683.2015.05.02 · Cited by 514
Lai, D., Ho, K. C., Hao, Y., & Yang, X. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2711 · Cited by 416
Metadata
- Authors
- McGrogan, B. T., Gilmartin, B., Carney, D. N., & McCann, A.
- Venue
- Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
- Publisher
- Elsevier BV
- Published
- 2008-04
- Volume
- 1785
- Issue
- 2
- Pages
- 96-132
- ISSN
- 0304-419X (ISSN-L)
- OpenAlex
- W2150406132
- Cited by
- 535
- References
- 337
- FWCI
- 10.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.